Skip to main content
Clinical Trials/IRCT20190929044923N1
IRCT20190929044923N1
Completed
Phase 3

A comparison of the effects of Heart Rate Control with Amiodarone and esmolol on Hemodynamic and Clinical Outcomes in Patients with Septic Shock

Tehran University of Medical Sciences0 sites30 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
30
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • septic shock receiving vasopressor despite adequate fluid therapy
  • Heart rate above 100 beats per minute for no apparent reason (such as fever, agitation, pain, anemia, and hypovolemia that should be treated before starting medication and hemodynamic tests)
  • Cardiac index above 2\.5 liters / minute per square meter
  • Absence of arrhythmia

Exclusion Criteria

  • treatment with beta\-blocker or amiodarone in the last 48 hours
  • Patient with heart valve problems
  • Pulmonary fibrosis
  • Hypo / Hyperthyroidism
  • Known pulmonary hypertension
  • History of amiodarone intolerance
  • Post CPR conditions
  • Aortic aneurysm
  • ARDS with PaO2 / FiO2 less than 150

Outcomes

Primary Outcomes

Not specified

Similar Trials